432 related articles for article (PubMed ID: 34028650)
1. Blood-brain barrier dysfunction as a potential therapeutic target for neurodegenerative disorders.
Uprety A; Kang Y; Kim SY
Arch Pharm Res; 2021 May; 44(5):487-498. PubMed ID: 34028650
[TBL] [Abstract][Full Text] [Related]
2. Age-associated physiological and pathological changes at the blood-brain barrier: A review.
Erdő F; Denes L; de Lange E
J Cereb Blood Flow Metab; 2017 Jan; 37(1):4-24. PubMed ID: 27837191
[TBL] [Abstract][Full Text] [Related]
3. P7C3-A20 treatment one year after TBI in mice repairs the blood-brain barrier, arrests chronic neurodegeneration, and restores cognition.
Vázquez-Rosa E; Shin MK; Dhar M; Chaubey K; Cintrón-Pérez CJ; Tang X; Liao X; Miller E; Koh Y; Barker S; Franke K; Crosby DR; Schroeder R; Emery J; Yin TC; Fujioka H; Reynolds JD; Harper MM; Jain MK; Pieper AA
Proc Natl Acad Sci U S A; 2020 Nov; 117(44):27667-27675. PubMed ID: 33087571
[TBL] [Abstract][Full Text] [Related]
4. Vascular Cell Senescence Contributes to Blood-Brain Barrier Breakdown.
Yamazaki Y; Baker DJ; Tachibana M; Liu CC; van Deursen JM; Brott TG; Bu G; Kanekiyo T
Stroke; 2016 Apr; 47(4):1068-77. PubMed ID: 26883501
[TBL] [Abstract][Full Text] [Related]
5. Functional morphology of the blood-brain barrier in health and disease.
Liebner S; Dijkhuizen RM; Reiss Y; Plate KH; Agalliu D; Constantin G
Acta Neuropathol; 2018 Mar; 135(3):311-336. PubMed ID: 29411111
[TBL] [Abstract][Full Text] [Related]
6. The "Frail" Brain Blood Barrier in Neurodegenerative Diseases: Role of Early Disruption of Endothelial Cell-to-Cell Connections.
Maiuolo J; Gliozzi M; Musolino V; Scicchitano M; Carresi C; Scarano F; Bosco F; Nucera S; Ruga S; Zito MC; Mollace R; Palma E; Fini M; Muscoli C; Mollace V
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30201915
[TBL] [Abstract][Full Text] [Related]
7. Impairment of pericyte-endothelium crosstalk leads to blood-brain barrier dysfunction following traumatic brain injury.
Bhowmick S; D'Mello V; Caruso D; Wallerstein A; Abdul-Muneer PM
Exp Neurol; 2019 Jul; 317():260-270. PubMed ID: 30926390
[TBL] [Abstract][Full Text] [Related]
8. Annexin A1 restores Aβ
Park JC; Baik SH; Han SH; Cho HJ; Choi H; Kim HJ; Choi H; Lee W; Kim DK; Mook-Jung I
Aging Cell; 2017 Feb; 16(1):149-161. PubMed ID: 27633771
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-107 prevents amyloid-beta induced blood-brain barrier disruption and endothelial cell dysfunction by targeting Endophilin-1.
Liu W; Cai H; Lin M; Zhu L; Gao L; Zhong R; Bi S; Xue Y; Shang X
Exp Cell Res; 2016 May; 343(2):248-257. PubMed ID: 27038654
[TBL] [Abstract][Full Text] [Related]
10. Factors controlling permeability of the blood-brain barrier.
Almutairi MM; Gong C; Xu YG; Chang Y; Shi H
Cell Mol Life Sci; 2016 Jan; 73(1):57-77. PubMed ID: 26403789
[TBL] [Abstract][Full Text] [Related]
11. The role of mutations associated with familial neurodegenerative disorders on blood-brain barrier function in an iPSC model.
Katt ME; Mayo LN; Ellis SE; Mahairaki V; Rothstein JD; Cheng L; Searson PC
Fluids Barriers CNS; 2019 Jul; 16(1):20. PubMed ID: 31303172
[TBL] [Abstract][Full Text] [Related]
12. Glia-induced reversible disruption of blood-brain barrier integrity and neuropathological response of the neurovascular unit.
Willis CL
Toxicol Pathol; 2011 Jan; 39(1):172-85. PubMed ID: 21189317
[TBL] [Abstract][Full Text] [Related]
13. Blood-Brain Barrier Dysfunction and the Pathogenesis of Alzheimer's Disease.
Yamazaki Y; Kanekiyo T
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28902142
[TBL] [Abstract][Full Text] [Related]
14. The role of the blood brain barrier in neurodegenerative disorders and their treatment.
Palmer AM
J Alzheimers Dis; 2011; 24(4):643-56. PubMed ID: 21460432
[TBL] [Abstract][Full Text] [Related]
15. Revisiting the blood-brain barrier: A hard nut to crack in the transportation of drug molecules.
Harilal S; Jose J; Parambi DGT; Kumar R; Unnikrishnan MK; Uddin MS; Mathew GE; Pratap R; Marathakam A; Mathew B
Brain Res Bull; 2020 Jul; 160():121-140. PubMed ID: 32315731
[TBL] [Abstract][Full Text] [Related]
16. The blood-brain barrier in health and chronic neurodegenerative disorders.
Zlokovic BV
Neuron; 2008 Jan; 57(2):178-201. PubMed ID: 18215617
[TBL] [Abstract][Full Text] [Related]
17. Blood-Brain Barrier and Neurodegenerative Diseases-Modeling with iPSC-Derived Brain Cells.
Wu YC; Sonninen TM; Peltonen S; Koistinaho J; Lehtonen Š
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299328
[TBL] [Abstract][Full Text] [Related]
18. The role of LINC00094/miR-224-5p (miR-497-5p)/Endophilin-1 axis in Memantine mediated protective effects on blood-brain barrier in AD microenvironment.
Zhu L; Lin M; Ma J; Liu W; Gao L; Wei S; Xue Y; Shang X
J Cell Mol Med; 2019 May; 23(5):3280-3292. PubMed ID: 30801976
[TBL] [Abstract][Full Text] [Related]
19. Multicellular 3D Neurovascular Unit Model for Assessing Hypoxia and Neuroinflammation Induced Blood-Brain Barrier Dysfunction.
Nzou G; Wicks RT; VanOstrand NR; Mekky GA; Seale SA; El-Taibany A; Wicks EE; Nechtman CM; Marrotte EJ; Makani VS; Murphy SV; Seeds MC; Jackson JD; Atala AJ
Sci Rep; 2020 Jun; 10(1):9766. PubMed ID: 32555384
[TBL] [Abstract][Full Text] [Related]
20. Apelin-13 Protects against Ischemic Blood-Brain Barrier Damage through the Effects of Aquaporin-4.
Chu H; Yang X; Huang C; Gao Z; Tang Y; Dong Q
Cerebrovasc Dis; 2017; 44(1-2):10-25. PubMed ID: 28402976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
